Morphic Therapeutic Enters into Integrin Research And Development Collaboration With Janssen
- Deal extends reach of Morphic discovery across all known human integrins
- Therapeutic potential of Morphic pipeline expanded by inclusion of both?integrin inhibitor and activator?research
- Collaboration facilitated by Johnson & Johnson Innovation, Boston